| Drug Name |
Desloratadine |
| Drug ID |
BADD_D00615 |
| Description |
Desloratadine is a second generation, tricyclic antihistamine that which has a selective and peripheral H1-antagonist action. It is the active descarboethoxy metabolite of loratidine (a second generation histamine). Desloratidine has a long-lasting effect and does not cause drowsiness because it does not readily enter the central nervous system. |
| Indications and Usage |
For the relief of symptoms of seasonal allergic rhinitis, perennial (non-seasonal) allergic rhinitis. Desloratidine is also used for the sympomatic treatment of pruritus and urticaria (hives) associated with chronic idiopathic urticaria. |
| Marketing Status |
Prescription |
| ATC Code |
R06AX27 |
| DrugBank ID |
DB00967
|
| KEGG ID |
D03693
|
| MeSH ID |
C121345
|
| PubChem ID |
124087
|
| TTD Drug ID |
D01GBY
|
| NDC Product Code |
53104-7613; 55111-073; 75895-0099; 65691-0057; 62993-0805; 62250-619; 51001-0034; 78206-119; 50090-4794; 53104-7688; 55111-551; 68180-153; 65015-698; 62756-481; 66039-830; 42291-240; 50090-3975; 55111-360; 50090-0765; 71335-1000; 62331-019; 66577-018; 69543-107 |
| Synonyms |
desloratadine | descarboethoxyloratadine | SCH 34117 | SCH-34117 | Clarinex | Neoclarityn | Aerius | descarboethoxyloratadine acetate |
